Damora Therapeutics (DMRA) Amortizatization of Intangibles (2019 - 2026)
Damora Therapeutics (DMRA) reported Amortizatization of Intangibles of $63000.0 for Q1 2026, up 2000.0% on a YoY basis from $3000.0 in Q1 2025, and up 6200.0% quarter-over-quarter from $1000.0 in Q4 2025.
Damora Therapeutics (DMRA) Amortizatization of Intangibles (2019 - 2026) Analysis & Trends
Damora Therapeutics has reported Amortizatization of Intangibles for 8 years, with the latest figure at $63000.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortizatization of Intangibles rose 2000.0% year-over-year to $63000.0; the trailing twelve-month figure through Mar 2026 stood at $72000.0 (up 191.14% YoY), and the FY2025 full-year result was $12000.0, up 117.14% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $63000.0, up from $1000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $743000.0 in Q3 2022, with the low at -$871000.0 in Q4 2022.
- Historically, Amortizatization of Intangibles has averaged -$8125.0 across 5 years, with a median of $18500.0 in 2023.
- Annual changes were most pronounced in 2024 — Amortizatization of Intangibles plunged 213.53% — and 2026, when it surged 2000.0%.
- Damora Therapeutics' Amortizatization of Intangibles stood at -$871000.0 in 2022, then jumped by 102.87% to $25000.0 in 2023, then plunged by 1040.0% to -$235000.0 in 2024, then surged by 100.43% to $1000.0 in 2025, then surged by 6200.0% to $63000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $63000.0 (Q1 2026), $1000.0 (Q4 2025), and $5000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Damora Therapeutics | 731.26 Mn | 528.86 Mn | - | 63,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 63,000.00 |
| Mar 31, 2026 | 63,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Jun 30, 2025 | 3,000.00 |
| Jun 30, 2025 | 3,000.00 |
| Mar 31, 2025 | 3,000.00 |
| Mar 31, 2025 | 3,000.00 |
| Sep 30, 2024 | -235,000.00 |
| Sep 30, 2024 | -235,000.00 |
| Jun 30, 2024 | 153,000.00 |
| Jun 30, 2024 | 153,000.00 |
| Mar 31, 2024 | 12,000.00 |
| Mar 31, 2024 | 12,000.00 |
| Dec 31, 2023 | 25,000.00 |
| Dec 31, 2023 | 25,000.00 |
| Sep 30, 2023 | 207,000.00 |
| Sep 30, 2023 | 207,000.00 |